videos

We sit down with Co-Chief Operating Officer, Steve Mason, to explore how Altasciences' full-service, integrated CRO platform benefits timelines and budgets in the preclinical and clinical phases of early drug development.

Tell Us Once™ is more than a tagline; it's our commitment to you.Your key customer information travels and evolves with your project as it advances, so you don't have to repeat yourself.

Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.

Cathy Konidas, Chief Commercial Officer at Altasciences, discusses our ability to be nimble to clients' specific needs and to changes happening in the industry.

Marie-Hélène Raigneau, Co-Chief Operating Officer at Altasciences, shares how caring for sponsors' programs and studiesis what sets Altasciences apart from other CDMO's and CRO's.

CEO Chris Perkin explains our Tell Us Once™ approach. Whether your partner with us for a complete lead candidate to proof of concept program, a single study, or something in between, we proactively share your preferences, and relevant program information across all phases, departments, and locations through an internal database that is always at our fingertips.

As an alternative to traditional venipuncture, blood microsampling represents a less invasive and simplified collection technique, resulting in numerous benefits for preclinical and clinical studies.